Halcyon Biotechnologies is a consumer life sciences company founded in 2016, based in the United States and focused on cognitive performance. The company's mission is to leverage science to enhance the quality of people's lives through cognitive health. Working directly with top scientists, psychologists, and health professionals globally, Halcyon translates scientific and technological advances into innovative products. The company's product development pipeline, guided by a Scientific Advisory Board, aims to develop safe and effective products and services for supporting human cognition proactively. Their first product, called HALCYON, is a proprietary formulation of ingredients aimed at producing a focused, motivated mental state and providing safe and effective nutrients clinically demonstrated to support cognition and long-term brain health at the cellular level. Each ingredient is empirically proven to support key aspects of human cognition, including memory, focus, and motivation using only FDA compliant compounds. With a focus on cognitive health and a strong emphasis on scientific validation, Halcyon Biotechnologies presents an intriguing entry into the Biotechnology industry.
There is no investment information
No recent news or press coverage available for Halcyon Biotechnologies.